Evidence map›Paper›PMID 39702262›Full record

ArticleArthritis research & therapy2024

Quantitative

Bo Broens, Esther J Nossent, Lilian J Meijboom, Gerben J C Zwezerijnen, Julia Spierings, Jeska K de Vries-Bouwstra, Jacob M van Laar, Conny J van der Laken, Alexandre E Voskuyl

Abstract read
In one paragraph

Article in Arthritis research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Pilot study ofRespiratory research · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bo BroensDepartment of Rheumatology and Clinical Immunology, Amsterdam UMC, Meibergdreef 9, Room G7-126, Amsterdam, 1105 AZ, the Netherlands.
Esther J NossentDepartment of Pulmonary Medicine, Amsterdam UMC, Amsterdam, the Netherlands.
Lilian J MeijboomAmsterdam Cardiovascular Sciences Research Institute, Amsterdam, the Netherlands.
Gerben J C ZwezerijnenDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, the Netherlands.
Julia SpieringsDepartment of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Jeska K de Vries-BouwstraDepartment of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
Jacob M van LaarDepartment of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Conny J van der LakenDepartment of Rheumatology and Clinical Immunology, Amsterdam UMC, Meibergdreef 9, Room G7-126, Amsterdam, 1105 AZ, the Netherlands.
Alexandre E VoskuylDepartment of Rheumatology and Clinical Immunology, Amsterdam UMC, Meibergdreef 9, Room G7-126, Amsterdam, 1105 AZ, the Netherlands. ae.voskuyl@amsterdamumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to assess the quantitative uptake of

methodsA prospective, cross-sectional study was conducted, involving 15 patients with SSc-ILD, 5 patients with SSc without ILD, and 7 controls without SSc.

results

conclusions

Indexed as

Fluorodeoxyglucose F18Lung Diseases, InterstitialPositron Emission Tomography Computed TomographyRadiopharmaceuticalsAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedProspective StudiesRespiratory Function TestsScleroderma, DiffuseSeverity of Illness IndexFluorodeoxyglucose F18RadiopharmaceuticalsImagingInterstitial lung diseasePositron Emission TomographySystemic sclerosis

Identifiers

PMID39702262
PMCPMC11657652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.